252 related articles for article (PubMed ID: 35155433)
1. Crosstalk Between Four Types of RNA Modification Writers Characterizes the Tumor Immune Microenvironment Infiltration Patterns in Skin Cutaneous Melanoma.
Zhang S; Xiong Y; Zheng C; Long J; Zhou H; Zeng Z; Ouyang Y; Tang F
Front Cell Dev Biol; 2022; 10():821678. PubMed ID: 35155433
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
[TBL] [Abstract][Full Text] [Related]
3. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
[TBL] [Abstract][Full Text] [Related]
4. RNA modification writers influence tumor microenvironment in gastric cancer and prospects of targeted drug therapy.
Song P; Zhou S; Qi X; Jiao Y; Gong Y; Zhao J; Yang H; Qian Z; Qian J; Tang L
J Bioinform Comput Biol; 2022 Apr; 20(2):2250004. PubMed ID: 35287562
[No Abstract] [Full Text] [Related]
5. Crosstalk of RNA Adenosine Modification-Related Subtypes, Establishment of a Prognostic Model, and Immune Infiltration Characteristics in Ovarian Cancer.
Ni X; Chen C; Cui G; Ding W; Liu J
Front Immunol; 2022; 13():932876. PubMed ID: 35837397
[TBL] [Abstract][Full Text] [Related]
6. RNA modification writer expression profiles predict clinical outcomes and guide neoadjuvant immunotherapy in non-small cell lung cancer.
Zhou B; Bie F; Zang R; Zhang M; Song P; Liu L; Peng Y; Bai G; Zhao J; Gao S
EBioMedicine; 2022 Oct; 84():104268. PubMed ID: 36116215
[TBL] [Abstract][Full Text] [Related]
7. Integrated investigation of the clinical implications and targeted landscape for RNA methylation modifications in hepatocellular carcinoma.
Zhang J; Gao J; Hu M; Xu S; Cheng C; Zheng W; Zhang J
Eur J Med Res; 2023 Jan; 28(1):46. PubMed ID: 36707911
[TBL] [Abstract][Full Text] [Related]
8. m
Chong W; Shang L; Liu J; Fang Z; Du F; Wu H; Liu Y; Wang Z; Chen Y; Jia S; Chen L; Li L; Chen H
Theranostics; 2021; 11(5):2201-2217. PubMed ID: 33500720
[TBL] [Abstract][Full Text] [Related]
9. m
Zhang B; Wu Q; Li B; Wang D; Wang L; Zhou YL
Mol Cancer; 2020 Mar; 19(1):53. PubMed ID: 32164750
[TBL] [Abstract][Full Text] [Related]
10. RNA M6A modification shaping cutaneous melanoma tumor microenvironment and predicting immunotherapy response.
Wu Y; He H; Zheng K; Qin Z; Cai N; Zuo S; Zhu X
Pigment Cell Melanoma Res; 2024 Jul; 37(4):496-509. PubMed ID: 38624045
[TBL] [Abstract][Full Text] [Related]
11. N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma.
Meijing Z; Tianhang L; Biao Y
Front Cell Dev Biol; 2022; 10():913307. PubMed ID: 35813200
[No Abstract] [Full Text] [Related]
12. Identification of m
Du F; Li H; Li Y; Liu Y; Li X; Dang N; Chu Q; Yan J; Fang Z; Wu H; Zhang Z; Zhu X; Li X
Front Cell Dev Biol; 2021; 9():761134. PubMed ID: 34993195
[TBL] [Abstract][Full Text] [Related]
13. Identification of anoikis-related subtypes and development of risk stratification system in skin cutaneous melanoma.
Tian J; Cao ZJ; Zhang Y; Zhou JK; Yang L
Heliyon; 2023 May; 9(5):e16153. PubMed ID: 37215879
[TBL] [Abstract][Full Text] [Related]
14. RNA modification "writer"-mediated RNA modification patterns and tumor microenvironment characteristics of cervical cancer.
Qu Y; Zhu H; Kong C; Zheng X; Wang D; Chen X; Yuan D
Clin Transl Oncol; 2022 Jul; 24(7):1413-1424. PubMed ID: 35220552
[TBL] [Abstract][Full Text] [Related]
15. Modeling cross-talk of RNA modification enzymes reveals tumor microenvironment-associated clinical significance and immunotherapy prediction in hepatobiliary malignancy.
Qi F; Li J; Qi Z; Zhou B; Yang B; Zhang J; Qin W
MedComm (2020); 2023 Jun; 4(3):e256. PubMed ID: 37090117
[TBL] [Abstract][Full Text] [Related]
16. A novel scoring model based on RNA modification "writers" can predict the prognosis and guide immunotherapy in gastric cancer.
Li X; Zhou Y; Jiang Q; Huang J; Liu Z; Li Y; Guo G
Funct Integr Genomics; 2023 May; 23(2):162. PubMed ID: 37188931
[TBL] [Abstract][Full Text] [Related]
17. The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma.
He W; Lin G; Pan C; Li W; Shen J; Liu Y; Li H; Wu D; Lin X
Front Genet; 2022; 13():761681. PubMed ID: 35154267
[No Abstract] [Full Text] [Related]
18. m
Sun M; Xie M; Zhang T; Wang Y; Huang W; Xia L
Front Immunol; 2021; 12():739768. PubMed ID: 34616403
[TBL] [Abstract][Full Text] [Related]
19. Cross-talk of RNA modification "writers" describes tumor stemness and microenvironment and guides personalized immunotherapy for gastric cancer.
Li Z; Zhang X; Weng W; Zhang G; Ren Q; Tian Y
Aging (Albany NY); 2023 Jun; 15(12):5445-5481. PubMed ID: 37319315
[TBL] [Abstract][Full Text] [Related]
20. M6A Classification Combined With Tumor Microenvironment Immune Characteristics Analysis of Bladder Cancer.
Zhu H; Jia X; Wang Y; Song Z; Wang N; Yang Y; Shi X
Front Oncol; 2021; 11():714267. PubMed ID: 34604051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
